Performance-enhancing effects of non-selective endothelin receptor antagonist

Int J Cardiol. 2014 Feb 1;171(2):294-7. doi: 10.1016/j.ijcard.2013.11.077. Epub 2013 Dec 4.
No abstract available

Keywords: Hepatic enzymes; Maximal oxygen uptake; Pulmonary arterial hypertension.

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Exercise Tolerance / drug effects*
  • Female
  • Humans
  • Male
  • Oxygen Consumption / drug effects*
  • Performance-Enhancing Substances / therapeutic use*
  • Placebo Effect
  • Sulfonamides / therapeutic use*
  • Young Adult

Substances

  • Antihypertensive Agents
  • Endothelin Receptor Antagonists
  • Performance-Enhancing Substances
  • Sulfonamides
  • Bosentan

Associated data

  • ClinicalTrials.gov/NCT01352065